Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Co-Diagnostics stock
Learn how to easily invest in Co-Diagnostics stock.
Co-Diagnostics Inc is a medical devices business based in the US. Co-Diagnostics shares (CODX) are listed on the NASDAQ and all prices are listed in US Dollars. Co-Diagnostics employs 101 staff and has a trailing 12-month revenue of around $78.2 million.
How to buy shares in Co-Diagnostics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CODX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Co-Diagnostics stock price (NASDAQ: CODX)Use our graph to track the performance of CODX stocks over time.
Co-Diagnostics shares at a glance
|Latest market close||$2.96|
|52-week range||$2.76 - $10.90|
|50-day moving average||$4.58|
|200-day moving average||$5.88|
|Wall St. target price||$13.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.94|
Buy Co-Diagnostics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Co-Diagnostics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Co-Diagnostics price performance over time
|1 week (2022-09-21)||1.37%|
|1 month (2022-08-26)||-16.62%|
|3 months (2022-06-28)||-41.85%|
|6 months (2022-03-28)||-51.87%|
|1 year (2021-09-28)||-69.89%|
|2 years (2020-09-28)||-79.15%|
|3 years (2019-09-27)||176.64%|
|5 years (2017-09-28)||6.12|
Is Co-Diagnostics stock undervalued or overvalued?
Valuing Co-Diagnostics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Co-Diagnostics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Co-Diagnostics's P/E ratio
Co-Diagnostics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3x. In other words, Co-Diagnostics shares trade at around 3x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Co-Diagnostics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $30.5 million.
The EBITDA is a measure of a Co-Diagnostics's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$78.2 million|
|Operating margin TTM||37.86%|
|Gross profit TTM||$86.3 million|
|Return on assets TTM||14.6%|
|Return on equity TTM||24.17%|
|Market capitalisation||$102 million|
TTM: trailing 12 months
Co-Diagnostics share dividends
We're not expecting Co-Diagnostics to pay a dividend over the next 12 months.
Co-Diagnostics share price volatility
Over the last 12 months, Co-Diagnostics's shares have ranged in value from as little as $2.76 up to $10.9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Co-Diagnostics's is -0.7691. This would suggest that Co-Diagnostics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Co-Diagnostics has bucked the trend.
Co-Diagnostics, Inc. , a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah. .
Co-Diagnostics in the news
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Co-Diagnostics, Inc. of Class Action Lawsuit and Upcoming Deadline – CODX
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kiromic, LifeStance, MINISO, and Co-Dx and Encourages Investors to Contact the Firm
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm’s Attorneys Before October Deadline in Securities Class Action
Frequently asked questionsWhat percentage of Co-Diagnostics is owned by insiders or institutions?
Currently 0.434% of Co-Diagnostics shares are held by insiders and 22.672% by institutions. How many people work for Co-Diagnostics?
Latest data suggests 101 work at Co-Diagnostics. When does the fiscal year end for Co-Diagnostics?
Co-Diagnostics's fiscal year ends in December. Where is Co-Diagnostics based?
Co-Diagnostics's address is: 2401 South Foothill Drive, Salt Lake City, UT, United States, 84109 What is Co-Diagnostics's ISIN number?
Co-Diagnostics's international securities identification number is: US1897631057 What is Co-Diagnostics's CUSIP number?
Co-Diagnostics's Committee on Uniform Securities Identification Procedures number is: 189763105
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert